EU aims to create ‘single market for medicines’ with overhaul of pharma rules
In its first review of pharmaceutical law in 20 years, the EU will reduce drug prices and improve availability by encouraging companies to launch new drugs across blocks or face increased competition from counterfeit manufacturers. We want to increase The European Commission is moving ahead with plans to reduce the number of years of market…